Magnesium sulfate and Activated partial thromboplastin time prolonged - a phase IV clinical study of FDA data

Summary:

We study 16,579 people who have side effects when taking Magnesium sulfate. Activated partial thromboplastin time prolonged is found, especially among people who are female, 60+ old, have been taking the drug for < 1 month, also take Lasix and have Atrial fibrillation/flutter.

The phase IV clinical study analyzes which people take Magnesium sulfate and have Activated partial thromboplastin time prolonged. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 26, 2023

16,579 people reported to have side effects when taking Magnesium sulfate.
Among them, 39 people (0.24%) have Activated partial thromboplastin time prolonged.

What is Magnesium sulfate?

Magnesium sulfate has active ingredients of magnesium sulfate. It is used in migraine. Currently, eHealthMe is studying from 17,025 Magnesium sulfate users.

What is Activated partial thromboplastin time prolonged?

Activated partial thromboplastin time prolonged is found to be associated with 1,435 drugs and 1,138 conditions by eHealthMe. Currently, we are studying 8,660 people who have Activated partial thromboplastin time prolonged.

Number of Magnesium sulfate and Activated partial thromboplastin time prolonged reports submitted per year:

Could Magnesium sulfate cause Activated partial thromboplastin time prolonged?

Time on Magnesium sulfate when people have Activated partial thromboplastin time prolonged *:

Gender of people who have Activated partial thromboplastin time prolonged when taking Magnesium sulfate *:

female: 66.67 %
male: 33.33 %

Age of people who have Activated partial thromboplastin time prolonged when taking Magnesium sulfate *:

Common drugs people take besides Magnesium sulfate *:

Common side effects people have besides Activated partial thromboplastin time prolonged *:

Hypotension (abnormally low blood pressure): 12 people, 30.77%
Haemoglobin Decreased: 9 people, 23.08%
Anaemia (lack of blood): 9 people, 23.08%
International Normalised Ratio Increased: 9 people, 23.08%
Thrombocytopenia (decrease of platelets in blood): 9 people, 23.08%
Fever: 7 people, 17.95%
Renal Failure Acute (rapid kidney dysfunction): 6 people, 15.38%
Acute Kidney Failure: 5 people, 12.82%
Loss Of Consciousness: 5 people, 12.82%
Haemorrhage (bleeding): 5 people, 12.82%

Common conditions people have *:

Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 7 people, 17.95%
High Blood Pressure: 5 people, 12.82%
Dementia (madness): 3 people, 7.69%
Sepsis (a severe blood infection that can lead to organ failure and death): 3 people, 7.69%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 7.69%
Hypoalbuminaemia (levels of albumin in blood serum are abnormally low): 2 people, 5.13%
Insomnia (sleeplessness): 2 people, 5.13%
Fever: 2 people, 5.13%
Fluid Retention (an abnormal accumulation of fluid in the blood): 2 people, 5.13%
Delirium (wild excitement): 2 people, 5.13%

* Approximation only. Some reports may have incomplete information.

Do you take Magnesium sulfate and have Activated partial thromboplastin time prolonged?

Check whether Activated partial thromboplastin time prolonged is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Magnesium sulfate side effects by duration, gender and age:

Magnesium sulfate side effects (17,025 reports)

Activated partial thromboplastin time prolonged treatments and more:

Activated partial thromboplastin time prolonged (8,660 reports)

Common drugs associated with Activated partial thromboplastin time prolonged:

All the drugs that are associated with Activated partial thromboplastin time prolonged:

Activated partial thromboplastin time prolonged (1,435 drugs)

Common conditions associated with Activated partial thromboplastin time prolonged:

Atrial fibrillation/flutter: 738 reports
High blood pressure: 249 reports
Sepsis: 195 reports
Stroke: 174 reports
Deep venous thrombosis: 150 reports
Pain: 136 reports

All the conditions that are associated with Activated partial thromboplastin time prolonged:

Activated partial thromboplastin time prolonged (1,138 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on magnesium sulfate (the active ingredients of Magnesium sulfate) and Magnesium sulfate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.